G Birgegard, M Bjorkholm, J Kutti, G Larfars, E Lofvenberg, B Markevarn, M Merup, J Palmblad, N Mauritzson, J Westin, J Samuelsson. Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders. haematol [Internet]. 2004May1 [cited 2024May17];89(5):520-7. Available from: https://haematologica.org/article/view/3073